Medifast, Inc. Stock Analysis & AI Score
Medifast, Inc. (MED) has an ST Score of 45.0 (C+), driven by its Forecast (A) and held back by its Sentiment (F). Analysts rate it Hold with a $59.67 price target (+400.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Consumer Cyclical |
| Industry | Personal Products & Services |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Medifast, Inc. (MED) has an ST Score of 45.0 (C+), driven by its Forecast (A) and held back by its Sentiment (F). Analysts rate it Hold with a $59.67 price target (+400.6% upside).
- Strongest
- ForecastA
- Weakest
- SentimentF
All factor grades
- ForecastA
- Financial StrengthA-
- MomentumA-
- ValuationC+
- GrowthD+
- ProfitabilityD
- SentimentF
- Piotroski3/9
Contact
MED stock: frequently asked questions
What is MED's ST Score?
Medifast, Inc. (MED) has an ST Score of 45.0 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MED a buy, hold, or sell?
Analysts rate MED a Hold, with a price target of $59.67 (+400.6% vs the current price). Our ST Score grades it C+ (45.0/100). The ST Score is a data-driven signal, not a recommendation.
What are MED's factor grades?
Valuation C+, Profitability D, Financial Strength A-, Momentum A-, Growth D+, Forecast A, Sentiment F.
What is MED's valuation grade?
Medifast, Inc. (MED) earns a valuation grade of C+, measured against Personal Products & Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MED's growth grade?
Medifast, Inc. (MED) earns a growth grade of D+, measured against Personal Products & Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MED's profitability grade?
Medifast, Inc. (MED) earns a profitability grade of D, measured against Personal Products & Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MED's financial strength grade?
Medifast, Inc. (MED) earns a financial strength grade of A-, measured against Personal Products & Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MED?
The average analyst price target for Medifast, Inc. (MED) is $59.67 from 12 analysts, which is +400.6% versus the recent price of $11.92.
What is MED's Piotroski score?
Medifast, Inc. (MED) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.